Rapport Therapeutics (RAPP) Depreciation and Depletion (2023 - 2026)
Rapport Therapeutics (RAPP) reported Depreciation and Depletion of $200000.0 for Q1 2026, little changed year-over-year from $200000.0 in Q1 2025, and little changed quarter-over-quarter from $200000.0 in Q4 2025.
Rapport Therapeutics (RAPP) Depreciation and Depletion (2023 - 2026) Analysis & Trends
Rapport Therapeutics (RAPP) has 4 years of Depreciation and Depletion data on file, last reported at $200000.0 in Q1 2026.
- Depreciation and Depletion for Q1 2026 came in at $200000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (up 25.0% YoY), and the FY2025 annual result was $1.0 million, up 25.0% from the prior year.
- Depreciation and Depletion held at $200000.0 in Q1 2026 per RAPP's latest filing, from $200000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $300000.0 in Q2 2025 and troughed at $23000.0 in Q3 2023.
- A 4-year average of $180333.3 and a median of $200000.0 in 2024 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2024 and 2025: Depreciation and Depletion soared 769.57% in 2024, then changed 0.0% in 2025.
- A 4-year view of Depreciation and Depletion shows it stood at $41000.0 in 2023, then jumped by 387.8% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025, then changed by 0.0% to $200000.0 in 2026.
- Business Quant data shows RAPP's Depreciation and Depletion at $200000.0 in Q1 2026, $200000.0 in Q4 2025, and $300000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Rapport Therapeutics | 1.66 Bn | 1.66 Bn | - | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Mar 31, 2025 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 41,000.00 |
| Dec 31, 2023 | 41,000.00 |